Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $65

Benzinga · 2d ago
Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $56 to $65.